TD Private Client Wealth LLC Has $709,000 Position in Encompass Health Co. (NYSE:EHC)

TD Private Client Wealth LLC boosted its position in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 2,870.0% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 7,336 shares of the company's stock after buying an additional 7,089 shares during the quarter. TD Private Client Wealth LLC's holdings in Encompass Health were worth $709,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in the company. UMB Bank n.a. raised its position in shares of Encompass Health by 387.7% during the 3rd quarter. UMB Bank n.a. now owns 317 shares of the company's stock valued at $31,000 after acquiring an additional 252 shares during the last quarter. V Square Quantitative Management LLC increased its holdings in Encompass Health by 53.0% in the third quarter. V Square Quantitative Management LLC now owns 404 shares of the company's stock valued at $39,000 after purchasing an additional 140 shares during the last quarter. Oakworth Capital Inc. acquired a new position in Encompass Health in the second quarter valued at about $40,000. Avior Wealth Management LLC bought a new position in Encompass Health during the third quarter worth about $40,000. Finally, Benjamin F. Edwards & Company Inc. increased its stake in shares of Encompass Health by 58.9% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 534 shares of the company's stock valued at $46,000 after acquiring an additional 198 shares during the last quarter. Institutional investors own 97.25% of the company's stock.

Analyst Ratings Changes

Several research analysts recently weighed in on the stock. Barclays lifted their price objective on shares of Encompass Health from $109.00 to $116.00 and gave the stock an "overweight" rating in a research note on Tuesday, October 29th. KeyCorp boosted their price target on shares of Encompass Health from $115.00 to $117.00 and gave the company an "overweight" rating in a report on Tuesday, October 29th. UBS Group raised their price objective on Encompass Health from $100.00 to $110.00 and gave the stock a "buy" rating in a research note on Wednesday, September 25th. Royal Bank of Canada boosted their target price on Encompass Health from $105.00 to $110.00 and gave the company an "outperform" rating in a research note on Wednesday, October 30th. Finally, Truist Financial reaffirmed a "buy" rating and set a $116.00 price target (up previously from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. Nine analysts have rated the stock with a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Buy" and a consensus price target of $107.11.

Encompass Health Stock Down 0.5 %

Shares of NYSE:EHC traded down $0.47 during mid-day trading on Friday, reaching $98.19. 523,446 shares of the stock were exchanged, compared to its average volume of 638,715. The stock's 50 day simple moving average is $99.35 and its 200-day simple moving average is $92.49. Encompass Health Co. has a one year low of $65.33 and a one year high of $104.55. The company has a market cap of $9.89 billion, a P/E ratio of 23.72, a P/E/G ratio of 1.34 and a beta of 0.86. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.88.

Encompass Health (NYSE:EHC - Get Free Report) last issued its quarterly earnings results on Monday, October 28th. The company reported $1.03 earnings per share for the quarter, topping the consensus estimate of $0.94 by $0.09. The company had revenue of $1.35 billion during the quarter, compared to analysts' expectations of $1.33 billion. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The business's quarterly revenue was up 11.9% on a year-over-year basis. During the same period last year, the business earned $0.86 EPS. As a group, equities research analysts predict that Encompass Health Co. will post 4.29 EPS for the current year.

Encompass Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be given a dividend of $0.17 per share. The ex-dividend date of this dividend is Thursday, January 2nd. This represents a $0.68 annualized dividend and a yield of 0.69%. Encompass Health's dividend payout ratio (DPR) is presently 16.43%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.